3-amino-5-hydroxybenzoic acid has been researched along with rifampin in 1 studies
| Studies (3-amino-5-hydroxybenzoic acid) | Trials (3-amino-5-hydroxybenzoic acid) | Recent Studies (post-2010) (3-amino-5-hydroxybenzoic acid) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 38 | 0 | 11 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | 3-amino-5-hydroxybenzoic acid (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggins, JB; Brady, SF; Braffman, N; Calle, PY; Campbell, EA; Danziger, M; Darst, SA; Fay, A; Glickman, MS; Lilic, M; Milshteyn, A; Montiel, D; Peek, J; Saito, K; Ternei, MA; Warrier, T; Woodworth, I | 1 |
1 other study(ies) available for 3-amino-5-hydroxybenzoic acid and rifampin
| Article | Year |
|---|---|
Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.
Topics: Aminobenzoates; Antibiotics, Antitubercular; Bacteria; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Hydroxybenzoates; Metagenomics; Molecular Structure; Mutation; Mycobacterium tuberculosis; Rifampin; Rifamycins; Soil Microbiology; Tuberculosis | 2018 |